All News

Somewhere in the United States, there may be a retail or specialty pharmacy that is not part of a group purchasing organization (GPO). If there is such a pharmacy, it is very hard to find.

Caught in the Middle

The furor over EpiPen pricing is simply the best publicized of many similar price hikes that have left patients unable to pay.

While FDA recently approved two new biosimilars for rheumatoid arthritis and other inflammatory diseases, questions remain about how quickly physicians and patients will embrace the new drugs.

Battling DIR Fees

The profitability of both chain and independent pharmacies is being affected by direct and indirect remuneration fees that insurers are retroactively charging pharmacies after filling Medicare Part D prescriptions.

In patients with COPD who have a history of exacerbations, a once-daily treatment regimen of combined fluticasone furoate and vilanterol was associated with fewer exacerbations than usual care without a greater risk of serious adverse events

New Mexico's state motto is “The Land of Enchantment,” but it might also be dubbed the The Land of Opportunity. Pharmacists here are increasingly breaking barriers to deliver frontline, provider care services in an environment that fosters innovations for the profession, students, and patients.

PBM giants cut drug expenses

When Express Scripts and CVS Health announced their 2017 formularies on August 1, a common theme emerged among the healthcare giants: several blockbuster drugs will be removed from both companies’ formularies and lower-cost options such as biosimilars are being embraced.

FDA approved Onzetra Xsail (Avanir Pharmaceuticals Inc.)- a fast-acting, low-dose sumatriptan dry powder formulation for the acute treatment of migraine with or without aura in adults.

Americans spend billions of dollars on products to address specific hair and scalp concerns each year-whether that be color, condition, or appearance.

Community pharmacists are caught in the middle of a battle between patients and their health insurers over how the federal government defines medical foods and how patients are paying for them.